Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Child survival and BCG vaccination: a community based prospective cohort study in Uganda
Victoria Nankabirwa1,2, James K Tumwine3, Proscovia M Mugaba4
1Department of Epidemiology and Biostatics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda. nankabirwav@gmail.com.
Insights
BCG vaccination in Uganda showed a significant association with reduced child mortality. This study highlights the protective, non-specific effects of BCG beyond tuberculosis prevention in African infants.
Area of Science:
- Immunology
- Public Health
- Pediatrics
Background:
- Limited data exists on the non-specific effects of Bacillus Calmette-Guérin (BCG) vaccination in African populations.
- Understanding these effects is crucial for public health strategies in regions with high infant mortality.
Purpose of the Study:
- To investigate the impact of BCG vaccination on post-neonatal infant and post-infancy mortality.
- To assess the association between BCG vaccination and child survival in a Ugandan cohort.
Main Methods:
- A prospective community-based cohort study followed 819 children in Mbale, Uganda, from birth to 5 years.
- Data on BCG vaccination status, collected from child health cards, were analyzed using multivariable Cox proportional hazards regression models.
- Maternal and household factors were considered as potential confounders.
Main Results:
- BCG vaccination was administered to 79% of children by 24 weeks of age, with a median age of 4 days.
- BCG vaccination was associated with a nearly 50% reduction in post-neonatal mortality (adjusted HR: 0.47).
- A significant association was found between BCG vaccination and a reduced mortality rate among children aged 1-5 years (adjusted HR: 0.26).
Conclusions:
- The risk of early childhood mortality in the study area is high.
- BCG vaccination demonstrated a significant association with improved child survival, suggesting beneficial non-specific effects.
Background:
Data on non-specific effects of BCG vaccination in well described, general population African cohorts is scanty. We report the effects of BCG vaccination on post-neonatal infant and post-infancy mortality in a cohort of children in Mbale, Eastern Uganda.
Methods:
A community-based prospective cohort study was conducted between January 2006 and February 2014. A total of 819 eligible pregnant women were followed up for pregnancy outcomes and survival of their children up to 5 years of age. Data on the children's BCG vaccination status was collected from child health cards at multiple visits between 3 weeks and 7 years of age. Data was also collected on mothers' residence, age, parity, household income, self-reported HIV status as well as place of birth. Multivariable Cox proportional hazards regression models taking into account potential confounders were used to estimate the association between BCG vaccination and child survival.
Results:
The neonatal mortality risk was 22 (95% CI: 13, 35), post-neonatal infant mortality 21 (12, 34) per 1,000 live births and the mortality risk among children between 1 and 5 years of age (post-infancy) was 63 (47, 82) per 1,000 live births. The median age at BCG vaccination was 4 days. Out of 819 children, 647 (79%) had received the BCG vaccine by 24 weeks of age. In the adjusted analysis, the rate of post-neonatal death among infants vaccinated with BCG tended to be nearly half of that among those who had not received the vaccine (adjusted HR: 0.47; 95% CI: 0.14, 1.53). BCG vaccination was associated with a lower rate of death among children between 1 and 5 years of age (adjusted HR: 0.26; 95% CI: 0.14, 0.48).
Conclusion:
The risk of early childhood death in Mbale, Uganda is unacceptably high. BCG vaccination was associated with an increased likelihood of child survival.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
Related Concept Videos
Principles of Disease Surveillance
Vaccinations
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Bias in Epidemiological Studies